[
  {
    "ts": null,
    "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Transcript",
    "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Q1 2025 Pfizer Inc Earnings Call EVENT DATE/TIME: APRIL 29, 2025 / 2:00PM GMT ...",
    "url": "https://finnhub.io/api/news?id=dd9fb8080e7193d1ef29223e20cb95919f4300595677e3d88bcdc7c4a13528f9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745958906,
      "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Transcript",
      "id": 134137702,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Q1 2025 Pfizer Inc Earnings Call EVENT DATE/TIME: APRIL 29, 2025 / 2:00PM GMT ...",
      "url": "https://finnhub.io/api/news?id=dd9fb8080e7193d1ef29223e20cb95919f4300595677e3d88bcdc7c4a13528f9"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
    "summary": "Shares of U.S. auto makers fell after GM earnings despite a prospective tariff announcement, JetBlue braces for earnings, and Wolfspeed extends its gains",
    "url": "https://finnhub.io/api/news?id=4e2a441a6f7bd1351ea550e83b1594d1eaaee563f558ab5e9de8770c8c79fb1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745957940,
      "headline": "These Stocks Moved the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
      "id": 134141478,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of U.S. auto makers fell after GM earnings despite a prospective tariff announcement, JetBlue braces for earnings, and Wolfspeed extends its gains",
      "url": "https://finnhub.io/api/news?id=4e2a441a6f7bd1351ea550e83b1594d1eaaee563f558ab5e9de8770c8c79fb1c"
    }
  },
  {
    "ts": null,
    "headline": "BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations",
    "summary": "BridgeBio's new heart drug — a rival to Pfizer's blockbuster Vyndaqel — smashed sales expectations in its first full quarter on the market.",
    "url": "https://finnhub.io/api/news?id=87ebf73fa38dcd3e0eafb973ab123e810df0a86ea48d60949509f397b851ef7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745956898,
      "headline": "BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations",
      "id": 134141750,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "BridgeBio's new heart drug — a rival to Pfizer's blockbuster Vyndaqel — smashed sales expectations in its first full quarter on the market.",
      "url": "https://finnhub.io/api/news?id=87ebf73fa38dcd3e0eafb973ab123e810df0a86ea48d60949509f397b851ef7e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Shares Rise on CEO’s Optimism on Threatened Drug Tariffs",
    "summary": "The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.",
    "url": "https://finnhub.io/api/news?id=3169ee8a66e52d3005ac4839789e8fffeef65e60cdd2fab7eeec95de17c4337e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745956020,
      "headline": "Pfizer Shares Rise on CEO’s Optimism on Threatened Drug Tariffs",
      "id": 134141751,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.",
      "url": "https://finnhub.io/api/news?id=3169ee8a66e52d3005ac4839789e8fffeef65e60cdd2fab7eeec95de17c4337e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Cuts Spending on Weaker Sales",
    "summary": "Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after the failure of its obesity pill. Goldman Sachs Healthcare Analyst Asad Haider has more on the story and what to expect from Pfizer.",
    "url": "https://finnhub.io/api/news?id=9a8399bbf6d17bba362303deb1afd7d927afdeefba5a9e7d64deabb7bff143c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745954449,
      "headline": "Pfizer Cuts Spending on Weaker Sales",
      "id": 134141752,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after the failure of its obesity pill. Goldman Sachs Healthcare Analyst Asad Haider has more on the story and what to expect from Pfizer.",
      "url": "https://finnhub.io/api/news?id=9a8399bbf6d17bba362303deb1afd7d927afdeefba5a9e7d64deabb7bff143c2"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
    "summary": "Health care stocks were rising Tuesday afternoon, with the NYSE Health Care Index adding 1.3% and th",
    "url": "https://finnhub.io/api/news?id=5433357d766ff1e98c4dc2990deb2115d79b40318e486d9c878b7fe6cc0e97e5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745950675,
      "headline": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
      "id": 134141753,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Health care stocks were rising Tuesday afternoon, with the NYSE Health Care Index adding 1.3% and th",
      "url": "https://finnhub.io/api/news?id=5433357d766ff1e98c4dc2990deb2115d79b40318e486d9c878b7fe6cc0e97e5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock’s 7% Yield Makes It Look Like a Junk Bond—But Better",
    "summary": "Stock market investors have been punishing  Pfizer’s  stock.  Given the stock’s generous 7% yield, maybe junk bond investors should take a look.  The venerable drug company, which also developed one of the first Covid-19 vaccines, has seen its share price languish lately.",
    "url": "https://finnhub.io/api/news?id=ee96f7429e860163163ad57b4eefb5aacc30b46edadb03f05ef025b2324313d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745950260,
      "headline": "Pfizer Stock’s 7% Yield Makes It Look Like a Junk Bond—But Better",
      "id": 134141754,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Stock market investors have been punishing  Pfizer’s  stock.  Given the stock’s generous 7% yield, maybe junk bond investors should take a look.  The venerable drug company, which also developed one of the first Covid-19 vaccines, has seen its share price languish lately.",
      "url": "https://finnhub.io/api/news?id=ee96f7429e860163163ad57b4eefb5aacc30b46edadb03f05ef025b2324313d9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer CEO: 'We should not have tariffs' on pharma",
    "summary": "Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to decide whether to place a 25% tariff on pharmaceutical imports.",
    "url": "https://finnhub.io/api/news?id=2276d69fd83f6f3729fafba195f76249fdb0800fd5f216e16dfaf12b3dcd2412",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745947001,
      "headline": "Pfizer CEO: 'We should not have tariffs' on pharma",
      "id": 134134078,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to decide whether to place a 25% tariff on pharmaceutical imports.",
      "url": "https://finnhub.io/api/news?id=2276d69fd83f6f3729fafba195f76249fdb0800fd5f216e16dfaf12b3dcd2412"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Shares Rise After Q1 Profit Beats, Reaffirms 2025 Outlook",
    "summary": "Pfizer Reaffirms 2025 Outlook, Excludes Unpredictable Trade Impacts",
    "url": "https://finnhub.io/api/news?id=d7935dcb206c25418833709cbaa092defe8f473f3738ab844c279cce92844e9a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745944564,
      "headline": "Pfizer Shares Rise After Q1 Profit Beats, Reaffirms 2025 Outlook",
      "id": 134141756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Reaffirms 2025 Outlook, Excludes Unpredictable Trade Impacts",
      "url": "https://finnhub.io/api/news?id=d7935dcb206c25418833709cbaa092defe8f473f3738ab844c279cce92844e9a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Q1 2025 Earnings Call Transcript",
    "summary": "Pfizer Inc. (NYSE:PFE) Q1 2025 Results Conference Call April 29, 2024 10:00 AM ETCompany ParticipantsFrancesca DeMartino - Chief Investment Relations...",
    "url": "https://finnhub.io/api/news?id=40f04f7c22e085cacfff8d77887d547252e56583e4f869a3cc502e815e531fb4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745941623,
      "headline": "Pfizer Inc. (PFE) Q1 2025 Earnings Call Transcript",
      "id": 134135893,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer Inc. (NYSE:PFE) Q1 2025 Results Conference Call April 29, 2024 10:00 AM ETCompany ParticipantsFrancesca DeMartino - Chief Investment Relations...",
      "url": "https://finnhub.io/api/news?id=40f04f7c22e085cacfff8d77887d547252e56583e4f869a3cc502e815e531fb4"
    }
  },
  {
    "ts": null,
    "headline": "SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO",
    "summary": "Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on SWTX and MKGAF stock post deal.",
    "url": "https://finnhub.io/api/news?id=9a252710b61b998d96f2d09cc804f1cd2b2ecace76754cace4f2800ee54a189d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745941611,
      "headline": "SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO",
      "id": 134135895,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2201085783/image_2201085783.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on SWTX and MKGAF stock post deal.",
      "url": "https://finnhub.io/api/news?id=9a252710b61b998d96f2d09cc804f1cd2b2ecace76754cace4f2800ee54a189d"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Rise as Fed-Cut Wagers Sink Treasury Yields: Markets Wrap",
    "summary": "(Bloomberg) -- Wall Street traders looked past weak economic data and Corporate America’s warnings to push stocks higher as bond yields fell on speculation the Federal Reserve will cut interest rates to prevent a recession.Most Read from BloombergNew York City Transit System Chips Away at Subway Fare EvasionNYC’s Congestion Toll Raised $159 Million in the First QuarterNewsom Says California Is Now the World’s Fourth-Biggest EconomyThe Last Thing US Transit Agencies Should Do NowAt Bryn Mawr, a M",
    "url": "https://finnhub.io/api/news?id=2c4d84389ee86c8067f0533b13f3bcb74e185204785293d014dbb5c0dac45697",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745940950,
      "headline": "Stocks Rise as Fed-Cut Wagers Sink Treasury Yields: Markets Wrap",
      "id": 134130761,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Wall Street traders looked past weak economic data and Corporate America’s warnings to push stocks higher as bond yields fell on speculation the Federal Reserve will cut interest rates to prevent a recession.Most Read from BloombergNew York City Transit System Chips Away at Subway Fare EvasionNYC’s Congestion Toll Raised $159 Million in the First QuarterNewsom Says California Is Now the World’s Fourth-Biggest EconomyThe Last Thing US Transit Agencies Should Do NowAt Bryn Mawr, a M",
      "url": "https://finnhub.io/api/news?id=2c4d84389ee86c8067f0533b13f3bcb74e185204785293d014dbb5c0dac45697"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales",
    "summary": "PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.",
    "url": "https://finnhub.io/api/news?id=78123b95d1542d5d3f08e018c01f70165da91a4b29bf9a24e98776cd4d1944d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745940840,
      "headline": "Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales",
      "id": 134141757,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.",
      "url": "https://finnhub.io/api/news?id=78123b95d1542d5d3f08e018c01f70165da91a4b29bf9a24e98776cd4d1944d4"
    }
  },
  {
    "ts": null,
    "headline": "Economic Data Deluge",
    "summary": "Economic Data Deluge.",
    "url": "https://finnhub.io/api/news?id=82b88436ddb2aa635e41fc9978b7d9257cb95c6f0860e96d03701c9004d96113",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745939460,
      "headline": "Economic Data Deluge",
      "id": 134131193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Economic Data Deluge.",
      "url": "https://finnhub.io/api/news?id=82b88436ddb2aa635e41fc9978b7d9257cb95c6f0860e96d03701c9004d96113"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Jones Shows Leadership As Nasdaq Hangs On; Amazon Takes Heat From White House (Live Coverage)",
    "summary": "The Dow Jones led the major indexes Tuesday midday as the S&P 500 lagged. Amazon.com retreated on White House comments.",
    "url": "https://finnhub.io/api/news?id=5ef5465f64dccf63acb417618425be46bccfdbac0a4c2d4e1328b7e404f29e54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745938331,
      "headline": "Stock Market Today: Dow Jones Shows Leadership As Nasdaq Hangs On; Amazon Takes Heat From White House (Live Coverage)",
      "id": 134131194,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Dow Jones led the major indexes Tuesday midday as the S&P 500 lagged. Amazon.com retreated on White House comments.",
      "url": "https://finnhub.io/api/news?id=5ef5465f64dccf63acb417618425be46bccfdbac0a4c2d4e1328b7e404f29e54"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Reports Mixed First Quarter, Affirms Full-Year Outlook",
    "summary": "Pfizer's (PFE) first-quarter earnings unexpectedly increased year on year even as sales fell below W",
    "url": "https://finnhub.io/api/news?id=0e2ff352cd4c75c76bef5f8c31ac05779f57096b51506a9b17125e310618c283",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745938030,
      "headline": "Pfizer Reports Mixed First Quarter, Affirms Full-Year Outlook",
      "id": 134131195,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's (PFE) first-quarter earnings unexpectedly increased year on year even as sales fell below W",
      "url": "https://finnhub.io/api/news?id=0e2ff352cd4c75c76bef5f8c31ac05779f57096b51506a9b17125e310618c283"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Eyes Acquisitions After Obesity Drug Setback",
    "summary": "With Q1 sales down 8% and Paxlovid slump, adds $1.2B in cost cuts through 2027",
    "url": "https://finnhub.io/api/news?id=a73d5b492ec3b4091b7cd43702198b703eece055ebb9fc99f9d01a3ea493f661",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745937141,
      "headline": "Pfizer Eyes Acquisitions After Obesity Drug Setback",
      "id": 134131196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "With Q1 sales down 8% and Paxlovid slump, adds $1.2B in cost cuts through 2027",
      "url": "https://finnhub.io/api/news?id=a73d5b492ec3b4091b7cd43702198b703eece055ebb9fc99f9d01a3ea493f661"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "summary": "Pfizer's (PFE) first quarter earnings were mixed, with sales coming in narrowly below Wall Street expectations. The pharmaceutical company has reaffirmed its 2025 outlook and announced plans for $1.2 billion in cost-cutting efforts, though the company says it's \"unable to predict\" the impact of US President Trump's tariffs. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Brad Smith and Madison Mills on Morning Brief to take a closer look at Pfizer's earnings print. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=2e945d0fac06e36b13b4dcbafdc3f0063d9e730ce510745adfbe44a2580cad55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745937075,
      "headline": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
      "id": 134130891,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's (PFE) first quarter earnings were mixed, with sales coming in narrowly below Wall Street expectations. The pharmaceutical company has reaffirmed its 2025 outlook and announced plans for $1.2 billion in cost-cutting efforts, though the company says it's \"unable to predict\" the impact of US President Trump's tariffs. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Brad Smith and Madison Mills on Morning Brief to take a closer look at Pfizer's earnings print. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=2e945d0fac06e36b13b4dcbafdc3f0063d9e730ce510745adfbe44a2580cad55"
    }
  },
  {
    "ts": null,
    "headline": "Trade Balance in Goods Hits All-Time Record, Plus Q1 Earnings",
    "summary": "Pre-market futures are mixed-to-flat once again, this time with the blue-chip Dow leading into positive territory.",
    "url": "https://finnhub.io/api/news?id=a0dee8d565ac0efdcf9388c83e06bcb468d464f3c5cc802a17d3729b504bda6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745936940,
      "headline": "Trade Balance in Goods Hits All-Time Record, Plus Q1 Earnings",
      "id": 134131198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pre-market futures are mixed-to-flat once again, this time with the blue-chip Dow leading into positive territory.",
      "url": "https://finnhub.io/api/news?id=a0dee8d565ac0efdcf9388c83e06bcb468d464f3c5cc802a17d3729b504bda6b"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics",
    "summary": "While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=1678083d47cb8d5900ff7ddc56ed8a111e48d8e8ae3a02a306c6f0943de7fa94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745935206,
      "headline": "Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics",
      "id": 134131199,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=1678083d47cb8d5900ff7ddc56ed8a111e48d8e8ae3a02a306c6f0943de7fa94"
    }
  },
  {
    "ts": null,
    "headline": "GM, UPS, Coca-Cola, Spotify: Stocks to watch today",
    "summary": "U.S. stock futures were mixed early Tuesday as markets braced for a high-stakes earnings deluge. Dow Jones Industrial Average futures rose 0.3%, while the S&P 500 was flat. Nasdaq futures ticked down slightly.",
    "url": "https://finnhub.io/api/news?id=23df8df4043425bace6441203213d479f1bd45d008dd52275c163eecca5ae799",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745932440,
      "headline": "GM, UPS, Coca-Cola, Spotify: Stocks to watch today",
      "id": 134131200,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "U.S. stock futures were mixed early Tuesday as markets braced for a high-stakes earnings deluge. Dow Jones Industrial Average futures rose 0.3%, while the S&P 500 was flat. Nasdaq futures ticked down slightly.",
      "url": "https://finnhub.io/api/news?id=23df8df4043425bace6441203213d479f1bd45d008dd52275c163eecca5ae799"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit",
    "summary": "Pfizer stock jumped Tuesday after the S&P 500 drugmaker beat first-quarter profit expectations on the back of savvy cost-cutting measures.",
    "url": "https://finnhub.io/api/news?id=63f6c3eb8b739e3830750cd270f2889e2d9a8961cc4be6d9560edb44e7476a98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745930962,
      "headline": "S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit",
      "id": 134131201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer stock jumped Tuesday after the S&P 500 drugmaker beat first-quarter profit expectations on the back of savvy cost-cutting measures.",
      "url": "https://finnhub.io/api/news?id=63f6c3eb8b739e3830750cd270f2889e2d9a8961cc4be6d9560edb44e7476a98"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook",
    "summary": "Pfizer  on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic.  Pfizer forecast 2025 sales of between $61 billion and $64 billion and earnings per share of between $2.80 and $3.00, though it didn’t include any impact related to potential tariffs.  Pfizer said it expects to save an additional $1.2 billion from using automation, artificial intelligence and other digital tools, bringing the company’s overall cost-cutting efforts to $7.7 billion by the end of 2027.",
    "url": "https://finnhub.io/api/news?id=596b3bac629728935026356a75c8f5d677367637c6fc198667915611ff8ed99b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745930880,
      "headline": "Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook",
      "id": 134131202,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer  on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business postpandemic.  Pfizer forecast 2025 sales of between $61 billion and $64 billion and earnings per share of between $2.80 and $3.00, though it didn’t include any impact related to potential tariffs.  Pfizer said it expects to save an additional $1.2 billion from using automation, artificial intelligence and other digital tools, bringing the company’s overall cost-cutting efforts to $7.7 billion by the end of 2027.",
      "url": "https://finnhub.io/api/news?id=596b3bac629728935026356a75c8f5d677367637c6fc198667915611ff8ed99b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (NYSE:PFE) Misses Q1 Revenue Estimates",
    "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=d5960daa25991857efea1c555b6092e3c937886ae4d9d0e9e850c74fadafd7a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745929455,
      "headline": "Pfizer (NYSE:PFE) Misses Q1 Revenue Estimates",
      "id": 134131203,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=d5960daa25991857efea1c555b6092e3c937886ae4d9d0e9e850c74fadafd7a9"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer leans on cost cuts to offset falling revenue",
    "summary": "Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research operations, highlighting its operational efficiency even as it reported lower...",
    "url": "https://finnhub.io/api/news?id=b7622ef7cd09af934040c6e0ee519b8723349b9a81cb729dd8b6674951716ca9",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745929285,
      "headline": "Pfizer leans on cost cuts to offset falling revenue",
      "id": 134130338,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research operations, highlighting its operational efficiency even as it reported lower...",
      "url": "https://finnhub.io/api/news?id=b7622ef7cd09af934040c6e0ee519b8723349b9a81cb729dd8b6674951716ca9"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
    "summary": "Shares of U.S. auto makers fell after GM earnings despite a prospective tariff announcement, JetBlue braces for earnings, and Wolfspeed extends its gains",
    "url": "https://finnhub.io/api/news?id=1151b2c836f02dd34e07ffe6c40faa79af2d9eabe1c6367bbb71db0e2fc9478e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745929080,
      "headline": "These Stocks Are Moving the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
      "id": 134130749,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of U.S. auto makers fell after GM earnings despite a prospective tariff announcement, JetBlue braces for earnings, and Wolfspeed extends its gains",
      "url": "https://finnhub.io/api/news?id=1151b2c836f02dd34e07ffe6c40faa79af2d9eabe1c6367bbb71db0e2fc9478e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs",
    "summary": "The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade probe.",
    "url": "https://finnhub.io/api/news?id=4acb42fffe49c31338a3f1afb8e59e90e06b77ab85d31cd9db53a841d2824b13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745929020,
      "headline": "Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs",
      "id": 134131205,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade probe.",
      "url": "https://finnhub.io/api/news?id=4acb42fffe49c31338a3f1afb8e59e90e06b77ab85d31cd9db53a841d2824b13"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE) Surpasses Q1 Earnings Estimates",
    "summary": "Pfizer (PFE) delivered earnings and revenue surprises of 43.75% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=724e61fce788f1ccd08ebb2c6641a61412a44dfee99b3aaf0ec93954819c4203",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745927704,
      "headline": "Pfizer (PFE) Surpasses Q1 Earnings Estimates",
      "id": 134130899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) delivered earnings and revenue surprises of 43.75% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=724e61fce788f1ccd08ebb2c6641a61412a44dfee99b3aaf0ec93954819c4203"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Gains After Earnings Beat. Tariffs Aren’t the Only Worry for Wall Street.",
    "summary": "The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.",
    "url": "https://finnhub.io/api/news?id=a902d30a02e802d205d8c9b260f3adc946a7db94300c7048ebd62888ff3d5196",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745927160,
      "headline": "Pfizer Stock Gains After Earnings Beat. Tariffs Aren’t the Only Worry for Wall Street.",
      "id": 134131207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.",
      "url": "https://finnhub.io/api/news?id=a902d30a02e802d205d8c9b260f3adc946a7db94300c7048ebd62888ff3d5196"
    }
  },
  {
    "ts": null,
    "headline": "If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today",
    "summary": "Things were going great, right until the point when they weren't.",
    "url": "https://finnhub.io/api/news?id=54457c0520f66ab2450c676553e9b9830d8dbe59b5019de1be60335d6923dbb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745927100,
      "headline": "If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today",
      "id": 134131208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Things were going great, right until the point when they weren't.",
      "url": "https://finnhub.io/api/news?id=54457c0520f66ab2450c676553e9b9830d8dbe59b5019de1be60335d6923dbb1"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer backs guidance but weak Paxlovid sales drag on first quarter",
    "summary": "Pfizer backs guidance but weak Paxlovid sales drag on first quarter",
    "url": "https://finnhub.io/api/news?id=f77d92e8a72dbe8ebf1426aad29f5deda3b68795da07a397595572d3d3e85c88",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745926882,
      "headline": "Pfizer backs guidance but weak Paxlovid sales drag on first quarter",
      "id": 134124972,
      "image": "",
      "related": "PFE",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f77d92e8a72dbe8ebf1426aad29f5deda3b68795da07a397595572d3d3e85c88"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Prepared Remarks",
    "summary": "First-Quarter 2025 Earnings Conference Call Prepared Remarks April 29, 2025 [Slide 4: Opening Remarks - Albert Bourla] Albert Bourla - Pfizer Inc. - Chairman...",
    "url": "https://finnhub.io/api/news?id=5aab337cbe72f642a407c6932985e2c9ea63f877b285a22d26c7272786645d1b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745926029,
      "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Prepared Remarks",
      "id": 134126638,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "First-Quarter 2025 Earnings Conference Call Prepared Remarks April 29, 2025 [Slide 4: Opening Remarks - Albert Bourla] Albert Bourla - Pfizer Inc. - Chairman...",
      "url": "https://finnhub.io/api/news?id=5aab337cbe72f642a407c6932985e2c9ea63f877b285a22d26c7272786645d1b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Infographic",
    "summary": "First Quarter 2025 Earnings Highlights $13.7B Revenue -6% Op Decline1 $0.52 Rep. Dil. EPS ...",
    "url": "https://finnhub.io/api/news?id=c75f63ab9f27ba335755e718437152b4a09eb7e6bf37aecf3a375bf92ea5e73b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745926028,
      "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Infographic",
      "id": 134126640,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "First Quarter 2025 Earnings Highlights $13.7B Revenue -6% Op Decline1 $0.52 Rep. Dil. EPS ...",
      "url": "https://finnhub.io/api/news?id=c75f63ab9f27ba335755e718437152b4a09eb7e6bf37aecf3a375bf92ea5e73b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries",
    "summary": "Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries",
    "url": "https://finnhub.io/api/news?id=5ddd691b854e81ee2f212e3cca1c28ff1ff6c677bdfad607c50c234d6a0cd06f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745925720,
      "headline": "Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries",
      "id": 134129515,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries",
      "url": "https://finnhub.io/api/news?id=5ddd691b854e81ee2f212e3cca1c28ff1ff6c677bdfad607c50c234d6a0cd06f"
    }
  },
  {
    "ts": null,
    "headline": "Biohaven secures $600m financing as it awaits FDA prodrug decision",
    "summary": "The biotech has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its spinocerebellar ataxia drug.",
    "url": "https://finnhub.io/api/news?id=b95c77a1465a8cc92a823144fb39b0bf9ed693cb46f2a8bd8d0250759e28f861",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745924781,
      "headline": "Biohaven secures $600m financing as it awaits FDA prodrug decision",
      "id": 134131209,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The biotech has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its spinocerebellar ataxia drug.",
      "url": "https://finnhub.io/api/news?id=b95c77a1465a8cc92a823144fb39b0bf9ed693cb46f2a8bd8d0250759e28f861"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Press Release",
    "summary": "g Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance Delivers Robust Earnings Performance, Successfully Navigating a...",
    "url": "https://finnhub.io/api/news?id=8e1f314a2afe3dccaf9b9d9ea13ded9fbd70915074b169c9d5fba6cb91d03f6d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745924715,
      "headline": "Pfizer : Quarterly Corporate Performance - First Quarter 2025 Press Release",
      "id": 134126328,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "g Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance Delivers Robust Earnings Performance, Successfully Navigating a...",
      "url": "https://finnhub.io/api/news?id=8e1f314a2afe3dccaf9b9d9ea13ded9fbd70915074b169c9d5fba6cb91d03f6d"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer reports mixed results in first quarter earnings, reiterates 2025 outlook",
    "summary": "Pfizer missed first quarter earnings Thursday amid a volatile macro environment.",
    "url": "https://finnhub.io/api/news?id=0882452f2d8f35af59afb40c902e6139821291c5fad7d3b69f0291f64f9c2eb0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745924256,
      "headline": "Pfizer reports mixed results in first quarter earnings, reiterates 2025 outlook",
      "id": 134130901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer missed first quarter earnings Thursday amid a volatile macro environment.",
      "url": "https://finnhub.io/api/news?id=0882452f2d8f35af59afb40c902e6139821291c5fad7d3b69f0291f64f9c2eb0"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Q1 Earnings Snapshot",
    "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported first-quarter profit of $2.97 billion. On a per-share basis, the New York-based company said it had profit of 52 cents.",
    "url": "https://finnhub.io/api/news?id=55754bd453c42bc561434d83616b6f180aa506fdbaf175b0bc5b27fbaca2042d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745924114,
      "headline": "Pfizer: Q1 Earnings Snapshot",
      "id": 134131211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK (AP) — Pfizer Inc. PFE) on Tuesday reported first-quarter profit of $2.97 billion. On a per-share basis, the New York-based company said it had profit of 52 cents.",
      "url": "https://finnhub.io/api/news?id=55754bd453c42bc561434d83616b6f180aa506fdbaf175b0bc5b27fbaca2042d"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Jones Leads As Nasdaq Lags; Spotify Sinks, Telehealth Name Soars On Partnership (Live Coverage)",
    "summary": "Stock Market Today: Dow Jones Leads As Nasdaq Lags; Spotify Sinks, Telehealth Name Soars On Partnership (Live Coverage)",
    "url": "https://finnhub.io/api/news?id=8b034c6699bf6907f8c1ac6caefcc48650002949f576deecb4bf70e670e34761",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745923931,
      "headline": "Stock Market Today: Dow Jones Leads As Nasdaq Lags; Spotify Sinks, Telehealth Name Soars On Partnership (Live Coverage)",
      "id": 134129495,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Stock Market Today: Dow Jones Leads As Nasdaq Lags; Spotify Sinks, Telehealth Name Soars On Partnership (Live Coverage)",
      "url": "https://finnhub.io/api/news?id=8b034c6699bf6907f8c1ac6caefcc48650002949f576deecb4bf70e670e34761"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer to cut costs by another $1.7 billion as quarterly revenue falls",
    "summary": "Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and reported lower first-quarter revenue due to declining sales...",
    "url": "https://finnhub.io/api/news?id=42334c6828b3c52e802fb8fccc1bd7baac2aace82cb1358e054d62de242d9ba5",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745923329,
      "headline": "Pfizer to cut costs by another $1.7 billion as quarterly revenue falls",
      "id": 134126060,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost-cutting to its manufacturing and research operations and reported lower first-quarter revenue due to declining sales...",
      "url": "https://finnhub.io/api/news?id=42334c6828b3c52e802fb8fccc1bd7baac2aace82cb1358e054d62de242d9ba5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID",
    "summary": "Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID",
    "url": "https://finnhub.io/api/news?id=58611075a7fa867b069d7b45c4dc7b9eaf358c7335cdb72dfaf856bd866f4229",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745920320,
      "headline": "Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID",
      "id": 134129516,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID",
      "url": "https://finnhub.io/api/news?id=58611075a7fa867b069d7b45c4dc7b9eaf358c7335cdb72dfaf856bd866f4229"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Pfizer Inc., Q1 2025 Earnings Call, Apr 29, 2025",
    "summary": "Presentation Operator MessageOperator Good day, everyone, and welcome to Pfizer's First Quarter 2025 Earnings Conference Call. Today's call is being recorded. \rAt this time, I would like to turn",
    "url": "https://finnhub.io/api/news?id=47b64d6e8edde28b63d63b41edd5cbbcf582dc19a7c9ba66acef2baa8225224b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745917200,
      "headline": "Transcript : Pfizer Inc., Q1 2025 Earnings Call, Apr 29, 2025",
      "id": 135393279,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Presentation Operator MessageOperator Good day, everyone, and welcome to Pfizer's First Quarter 2025 Earnings Conference Call. Today's call is being recorded. \rAt this time, I would like to turn",
      "url": "https://finnhub.io/api/news?id=47b64d6e8edde28b63d63b41edd5cbbcf582dc19a7c9ba66acef2baa8225224b"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inches Down On Mixed Report As Cost Cuts Boost Earnings",
    "summary": "Pfizer Inches Down On Mixed Report As Cost Cuts Boost Earnings",
    "url": "https://finnhub.io/api/news?id=5b0898cfbf934e1c90b58d13fe7de4937203d6a05dd9b55bedfd58023b42bff6",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745916562,
      "headline": "Pfizer Inches Down On Mixed Report As Cost Cuts Boost Earnings",
      "id": 134129496,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Pfizer Inches Down On Mixed Report As Cost Cuts Boost Earnings",
      "url": "https://finnhub.io/api/news?id=5b0898cfbf934e1c90b58d13fe7de4937203d6a05dd9b55bedfd58023b42bff6"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Cut Alert: 2 Popular High Yields Getting Too Risky",
    "summary": "Chasing sky-high dividends could be setting you up for a painful payout cut. Find out 2 popular high-yield stocks flashing major warning signs.",
    "url": "https://finnhub.io/api/news?id=00ceee41e467c64d4a1e9af044fdbb19eed789a8ddaca73c67d03bc8d93ce269",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745915400,
      "headline": "Dividend Cut Alert: 2 Popular High Yields Getting Too Risky",
      "id": 134125010,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196723459/image_2196723459.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Chasing sky-high dividends could be setting you up for a painful payout cut. Find out 2 popular high-yield stocks flashing major warning signs.",
      "url": "https://finnhub.io/api/news?id=00ceee41e467c64d4a1e9af044fdbb19eed789a8ddaca73c67d03bc8d93ce269"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Patent Cliff Nears, Danuglipron Dreams Fade Away",
    "summary": "Pfizer: Undervalued with high dividends but facing challenges. Explore why sentiment remains weak and if downward trends persist.",
    "url": "https://finnhub.io/api/news?id=1ee9e6f25a10fb62cd2b5dc06568f8ce1817e299ed5e8fcee97dc6a2710509d5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745915349,
      "headline": "Pfizer: Patent Cliff Nears, Danuglipron Dreams Fade Away",
      "id": 134125017,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1913356496/image_1913356496.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer: Undervalued with high dividends but facing challenges. Explore why sentiment remains weak and if downward trends persist.",
      "url": "https://finnhub.io/api/news?id=1ee9e6f25a10fb62cd2b5dc06568f8ce1817e299ed5e8fcee97dc6a2710509d5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer 1Q Revenue Slides as Paxlovid Sales Fade",
    "summary": "By Dean Seal Pfizer recorded lower first-quarter revenue on a 75% drop in sales of its Covid-19 treatment, which more than offset growth in other drugs and product categories. The drugmaker...",
    "url": "https://finnhub.io/api/news?id=ec3c020b49389de75e0a5316f3af9f98a0cf7178a50a34cd05b57b0bb144ecf4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745911508,
      "headline": "Pfizer 1Q Revenue Slides as Paxlovid Sales Fade",
      "id": 134124285,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "By Dean Seal Pfizer recorded lower first-quarter revenue on a 75% drop in sales of its Covid-19 treatment, which more than offset growth in other drugs and product categories. The drugmaker...",
      "url": "https://finnhub.io/api/news?id=ec3c020b49389de75e0a5316f3af9f98a0cf7178a50a34cd05b57b0bb144ecf4"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer beats profit estimates on cost cuts, heart drug sales",
    "summary": "U.S. drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts and better-than-expected sales of its heart disease drug, Vyndaqel. On...",
    "url": "https://finnhub.io/api/news?id=827e9e4787e4eb929b1bece9a0c0419634e181377f5576504d8f05c93c87fc31",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745910139,
      "headline": "Pfizer beats profit estimates on cost cuts, heart drug sales",
      "id": 134124114,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. drugmaker Pfizer reported first-quarter profit above Wall Street estimates on Tuesday, helped by cots cuts and better-than-expected sales of its heart disease drug, Vyndaqel. On...",
      "url": "https://finnhub.io/api/news?id=827e9e4787e4eb929b1bece9a0c0419634e181377f5576504d8f05c93c87fc31"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : First Quarter 2025 Earnings Teleconference",
    "summary": "First Quarter 2025 Earnings Teleconference April 29, 2025 1 ...",
    "url": "https://finnhub.io/api/news?id=2bdfafa2f4c14e172add209382a8056481090e56479345e852445aff2fcd2d8e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745910010,
      "headline": "Pfizer : First Quarter 2025 Earnings Teleconference",
      "id": 134124029,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "First Quarter 2025 Earnings Teleconference April 29, 2025 1 ...",
      "url": "https://finnhub.io/api/news?id=2bdfafa2f4c14e172add209382a8056481090e56479345e852445aff2fcd2d8e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : First Quarter 2025 Infographic",
    "summary": "First Quarter 2025 Earnings Highlights $13.7B Revenue -6% Op Decline1 $0.52 Rep. Dil. EPS ...",
    "url": "https://finnhub.io/api/news?id=fce80ae6969632bd4a26783132bd96138e7ef562760a26f3a22e0baa4e671874",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745909349,
      "headline": "Pfizer : First Quarter 2025 Infographic",
      "id": 134123980,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "First Quarter 2025 Earnings Highlights $13.7B Revenue -6% Op Decline1 $0.52 Rep. Dil. EPS ...",
      "url": "https://finnhub.io/api/news?id=fce80ae6969632bd4a26783132bd96138e7ef562760a26f3a22e0baa4e671874"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance",
    "summary": "Delivers Robust Earnings Performance, Successfully Navigating a Dynamic EnvironmentMade Significant Progress Strengthening the R&D OrganizationOn Track to Exceed Net Cost Savings Targets...",
    "url": "https://finnhub.io/api/news?id=20ae469fd47cf5afdd5dfe6ad00ffb43dc1b941c3276b15236d142fe645cf3a4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745909163,
      "headline": "Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance",
      "id": 134123935,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Delivers Robust Earnings Performance, Successfully Navigating a Dynamic EnvironmentMade Significant Progress Strengthening the R&D OrganizationOn Track to Exceed Net Cost Savings Targets...",
      "url": "https://finnhub.io/api/news?id=20ae469fd47cf5afdd5dfe6ad00ffb43dc1b941c3276b15236d142fe645cf3a4"
    }
  },
  {
    "ts": null,
    "headline": "Starbucks, PayPal and Spotify feature in big slate of earnings",
    "summary": "Starbucks, PayPal and Spotify feature in big slate of earnings",
    "url": "https://finnhub.io/api/news?id=da8ed137affcb1e3649c61e94fe4b38818399e58c8982dd87ac87cff0cf0d438",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745902954,
      "headline": "Starbucks, PayPal and Spotify feature in big slate of earnings",
      "id": 134126996,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Starbucks, PayPal and Spotify feature in big slate of earnings",
      "url": "https://finnhub.io/api/news?id=da8ed137affcb1e3649c61e94fe4b38818399e58c8982dd87ac87cff0cf0d438"
    }
  }
]